Information:
Fel:
ID
34044
Beskrivning
Phosphorylation of ERK1/2 in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01142739
Länk
https://clinicaltrials.gov/show/NCT01142739
Nyckelord
Versioner (1)
- 2019-01-12 2019-01-12 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
12 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Parkinson Disease NCT01142739
Eligibility Parkinson Disease NCT01142739
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson Disease NCT01142739
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Parkinson Disease | Inpatient | Outpatients
Item
consecutive eligible pd in- and outpatients selected at the university hospital of bordeaux.
boolean
C0030567 (UMLS CUI [1])
C0021562 (UMLS CUI [2])
C0029921 (UMLS CUI [3])
C0021562 (UMLS CUI [2])
C0029921 (UMLS CUI [3])
Dementia Absent | Informed Consent | Social security recipient
Item
non-demented patients (dsm iv) who are able to give their informed consent and who are affiliated to the social security.
boolean
C0497327 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
C0682299 (UMLS CUI [3])
C0332197 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
C0682299 (UMLS CUI [3])
Controls | Nervous system disorder Absent | Dementia Absent | Informed Consent | Social security recipient
Item
controls: subjects without known neurological disorder, non-demented, able to give their informed consent and affiliated to the social security.
boolean
C0009932 (UMLS CUI [1])
C0027765 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0497327 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0021430 (UMLS CUI [4])
C0682299 (UMLS CUI [5])
C0027765 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0497327 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0021430 (UMLS CUI [4])
C0682299 (UMLS CUI [5])
Atypical Parkinson Disease | Secondary Parkinson Disease
Item
patients: atypical or secondary parkinson disease.
boolean
C1868596 (UMLS CUI [1])
C0030569 (UMLS CUI [2])
C0030569 (UMLS CUI [2])
Malignant Neoplasms | Hematological Disease Malignant
Item
previous or current cancer or malignant haemopathy.
boolean
C0006826 (UMLS CUI [1])
C0018939 (UMLS CUI [2,1])
C0205282 (UMLS CUI [2,2])
C0018939 (UMLS CUI [2,1])
C0205282 (UMLS CUI [2,2])
Autoimmune Disease
Item
known auto-immune disease.
boolean
C0004364 (UMLS CUI [1])
Antineoplastic Therapy | Immunomodulation | Adrenal Cortex Hormones | Immunodeficiency
Item
anti-neoplastic or immuno-modulator treatment (particularly corticosteroids). immuno-deficient subjects.
boolean
C2346834 (UMLS CUI [1])
C1963758 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
C0021051 (UMLS CUI [4])
C1963758 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
C0021051 (UMLS CUI [4])
Virus Disease | Statins | Dementia
Item
acute viral infection (within 2 weeks after resolving). statin drug intake. demented subject (dsmiv).
boolean
C0042769 (UMLS CUI [1])
C0360714 (UMLS CUI [2])
C0497327 (UMLS CUI [3])
C0360714 (UMLS CUI [2])
C0497327 (UMLS CUI [3])
Controls | Exclusion Criteria Same | Nervous system disorder
Item
controls: same criteria as above plus any neurological disease.
boolean
C0009932 (UMLS CUI [1])
C0680251 (UMLS CUI [2,1])
C0445247 (UMLS CUI [2,2])
C0027765 (UMLS CUI [3])
C0680251 (UMLS CUI [2,1])
C0445247 (UMLS CUI [2,2])
C0027765 (UMLS CUI [3])